We have already seen a MORE then doubling of survival in the phase IIb trial. Many had confirmed this at the NYC conference last year. Now the FDA has set the bar so low for SUNRISE, a trial halt is certain imo, my guess shortly after Peregrine's PR of trial fully enrolled.
My guess trial halted late summer 2015. Share price we can all speculate and debate but certainly many multiples higher.
News 
Market Data 
Discover 
AI
